A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis

BACKGROUND: To date, measurement of intracellular cystine is used for the therapeutic monitoring of patients affected by cystinosis in treatment with cysteamine. Since this method is time and sample consuming, development of a faster method to quantify cysteamine would be extremely useful in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzin, Martina, Rossetto, Silvia, Ruoso, Rachele, Del Savio, Rossella, Stocco, Gabriele, Decorti, Giuliana, Addobbati, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632017/
https://www.ncbi.nlm.nih.gov/pubmed/36329442
http://dx.doi.org/10.1186/s13023-022-02540-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632017/
https://www.ncbi.nlm.nih.gov/pubmed/36329442
http://dx.doi.org/10.1186/s13023-022-02540-1

Ejemplares similares